Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain.
about
The role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatmentsA low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel diseaseNeurobiological mechanisms of pelvic painIrritable bowel syndrome: a clinical reviewReceptors and transmission in the brain-gut axis: potential for novel therapies. I. Receptors on visceral afferents.Visceral perception: inflammatory and non-inflammatory mediators.Drug management of visceral pain: concepts from basic research.Rectal Mechano-sensory Function in Patients with Carcinoid Diarrhea.Peripheral corticotropin releasing hormone mediates post-inflammatory visceral hypersensitivity in rats.Irritable bowel syndrome: a practical approach.Visceral pain triggered by traction on the ileocecal ligament with ileitis.The future of GI and liver research: editorial perspectives. IV. Visceral afferents: an update.Monoaminergic modulation of spinal viscero-sympathetic function in the neonatal mouse thoracic spinal cord.Serotonin type-3 receptors mediate cholecystokinin-induced satiation through gastric distension.Tricyclic antidepressant amitriptyline inhibits 5-hydroxytryptamine 3 receptor currents in NCB-20 cells
P2860
Q26739291-D7214401-EBEA-40EE-BD84-542868DDAFBCQ27335631-F8586490-665C-410C-B2C2-3C9AE5C1FF28Q33992977-70B334F5-4912-4409-A741-010BF4EC1D3CQ34168517-D0F5E10C-269B-4378-AA43-EE127A019269Q34211931-4445A316-33E2-40F0-A40E-C39F16C317E8Q34699790-002F6622-DE16-4D32-843E-682F5018D962Q35947915-63662043-6D29-4A86-BD51-F3A94B218FDDQ36762652-FE6E3A3A-0511-43B1-9925-9FAD8ACB2949Q37196875-4A8CC6F7-56F2-4EEC-B396-F0A635DF2EC4Q37205398-9B481E05-774B-4038-A5C0-F65D086971E5Q37316831-2C776F96-08A3-4FE1-8399-96F1375039CCQ40589723-AAB4BED9-4D69-450F-ABAD-3CBAFF7843C3Q41471294-FA317A09-53CF-4030-A323-29E7397D98A8Q46949645-4C66DC5E-28D3-4253-BADA-82702AEFE95CQ58700987-33AFC584-E544-457A-AFA5-9C8F3B9CAC3E
P2860
Pathobiology of visceral pain: molecular mechanisms and therapeutic implications. III. Visceral afferent pathways: a source of new therapeutic targets for abdominal pain.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Pathobiology of visceral pain: ...... ic targets for abdominal pain.
@ast
Pathobiology of visceral pain: ...... ic targets for abdominal pain.
@en
type
label
Pathobiology of visceral pain: ...... ic targets for abdominal pain.
@ast
Pathobiology of visceral pain: ...... ic targets for abdominal pain.
@en
prefLabel
Pathobiology of visceral pain: ...... ic targets for abdominal pain.
@ast
Pathobiology of visceral pain: ...... ic targets for abdominal pain.
@en
P2860
P1476
Pathobiology of visceral pain: ...... tic targets for abdominal pain
@en
P2093
P2860
P304
P356
10.1152/AJPGI.2000.278.5.G670
P577
2000-05-01T00:00:00Z